Dealing with the itchy, scaly patches that come with psoriasis is difficult enough. But having psoriasis puts you at risk of ...

Psoriatic arthritis (PsA) is less common among Black people compared to other races, but differences in prevalence may also ...

While many believe the agents to be potential game changers, evidence is still lacking in psoriatic disease, and experts urge ...

Sponsored by Takeda As a Black doctor specializing in psoriatic arthritis (PsA), I have noticed the difficulties in ...

If psoriasis runs in your family, you may carry the genes—but lifestyle choices and early care can make all the difference in ...

Kayakalp Global, an integrative dermatology center, announced positive in vitro lab results for its Psorcure Oil, a steroid ...

Icotrokinra is currently being developed through a licensing and collaboration agreement between Protagonist and J&J.

Johnson & Johnson eyes FDA nod to icotrokinra after phase III studies show strong skin clearance and safety in plaque ...

The likelihood of reduced quality of life and high symptom burden in patients with psoriasis was similar across those with low, medium, and high BSA.

Icotrokinra was jointly discovered and is being developed pursuant to the license and collaboration agreement between ...

New research identifies diabetes as an independent predictor of major adverse cardiovascular events in patients with both ...

From polyaphron technology to fixed combinations, new formulations improve tolerability, adherence, and patient satisfaction. Join Drs Feldman and Armstrong as they discuss.